C
5.49
-0.11 (-1.96%)
| Previous Close | 5.60 |
| Open | 5.57 |
| Volume | 539,754 |
| Avg. Volume (3M) | 751,575 |
| Market Cap | 301,374,080 |
| Price / Sales | 436.42 |
| Price / Book | 3.29 |
| 52 Weeks Range | |
| Earnings Date | 13 Nov 2025 |
| Diluted EPS (TTM) | -1.33 |
| Total Debt/Equity (MRQ) | 14.61% |
| Current Ratio (MRQ) | 4.64 |
| Operating Cash Flow (TTM) | -27.20 M |
| Levered Free Cash Flow (TTM) | -8.33 M |
| Return on Assets (TTM) | -32.31% |
| Return on Equity (TTM) | -98.14% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | Candel Therapeutics, Inc. | Bullish | Bearish |
AIStockmoo Score
0.6
| Analyst Consensus | 5.0 |
| Insider Activity | NA |
| Price Volatility | -1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -2.5 |
| Average | 0.63 |
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 17.53% |
| % Held by Institutions | 40.72% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Acorn Capital Advisors, Llc | 30 Jun 2025 | 2,580,517 |
| Sands Capital Alternatives, Llc | 30 Jun 2025 | 405,837 |
| Tanager Wealth Management Llp | 30 Sep 2025 | 198,175 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 23.00 (HC Wainwright & Co., 318.94%) | Buy |
| Median | 15.50 (182.33%) | |
| Low | 7.00 (B of A Securities, 27.51%) | Hold |
| Average | 15.25 (177.78%) | |
| Total | 3 Buy, 1 Hold | |
| Avg. Price @ Call | 5.40 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stephens & Co. | 28 Oct 2025 | 15.00 (173.22%) | Buy | 5.60 |
| LifeSci Capital | 21 Oct 2025 | 16.00 (191.44%) | Buy | 5.49 |
| HC Wainwright & Co. | 29 Sep 2025 | 23.00 (318.94%) | Buy | 5.40 |
| B of A Securities | 03 Sep 2025 | 7.00 (27.50%) | Hold | 5.11 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |